These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 8151617)

  • 1. Synthesis of selective non-Ca(2+)-mobilizing inhibitors of D-myo-inositol 1,4,5-trisphosphate 5-phosphatase.
    Lampe D; Liu C; Potter BV
    J Med Chem; 1994 Apr; 37(7):907-12. PubMed ID: 8151617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design of potent and selective inhibitors of myo-inositol 1,4,5-trisphosphate 5-phosphatase.
    Safrany ST; Mills SJ; Liu C; Lampe D; Noble NJ; Nahorski SR; Potter BV
    Biochemistry; 1994 Sep; 33(35):10763-9. PubMed ID: 8075077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of 1L-chiro-inositol 2,3,5-trisphosphorothioate, the first partial agonist at the platelet myo-inositol 1,4,5-trisphosphate receptor.
    Liu C; al-Hafidh J; Westwick J; Potter BV
    Bioorg Med Chem; 1994 Apr; 2(4):253-7. PubMed ID: 7922136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic phosphorothioate-containing analogues of inositol 1,4,5-trisphosphate mobilize intracellular Ca2+ stores and interact differentially with inositol 1,4,5-trisphosphate 5-phosphatase and 3-kinase.
    Safrany ST; Wojcikiewicz RJ; Strupish J; McBain J; Cooke AM; Potter BV; Nahorski SR
    Mol Pharmacol; 1991 Jun; 39(6):754-61. PubMed ID: 1646949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unambiguous total synthesis of the enantiomers of myo-inositol 1,3,4-trisphosphate: 1L-myo-inositol 1,3,4-trisphosphate mobilizes intracellular Ca2+ in Limulus photoreceptors.
    Riley AM; Payne R; Potter BV
    J Med Chem; 1994 Nov; 37(23):3918-27. PubMed ID: 7966153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium release activity and metabolism of inositol 1,4,5-trisphosphate in T cells. Modulation by novel inositol 1,4,5-trisphosphate 5-phosphatase inhibitors.
    Ward SG; Lampe D; Liu C; Potter BV; Westwick J
    Eur J Biochem; 1994 Jun; 222(2):515-23. PubMed ID: 8020489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of potent Ins(1,4,5)P3 5-phosphatase inhibitors by modification of myo-inositol 1,3,4,6-tetrakisphosphate.
    Mills SJ; Potter BV
    Bioorg Med Chem; 2003 Sep; 11(19):4245-53. PubMed ID: 12951155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetic analysis of novel inhibitors of inositol polyphosphate metabolism.
    Hansbro PM; Foster PS; Liu C; Potter BV; Denborough MA
    Biochem Biophys Res Commun; 1994 Apr; 200(1):8-15. PubMed ID: 8166746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inositol-1,3,4,5-tetrakisphosphate induces calcium mobilization via the inositol-1,4,5-trisphosphate receptor in SH-SY5Y neuroblastoma cells.
    Wilcox RA; Challiss RA; Liu C; Potter BV; Nahorski SR
    Mol Pharmacol; 1993 Oct; 44(4):810-7. PubMed ID: 8232232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. myo-inositol 1,4,5-trisphosphorothioate is a potent competitive inhibitor of human erythrocyte 5-phosphatase.
    Cooke AM; Nahorski SR; Potter BV
    FEBS Lett; 1989 Jan; 242(2):373-7. PubMed ID: 2536622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and Ca(2+)-release activity of D- and L-myo-inositol 2,4,5-trisphosphate and D- and L-chiro-inositol 1,3,4-trisphosphate.
    Tegge W; Denis GV; Ballou CE
    Carbohydr Res; 1991 Sep; 217():107-16. PubMed ID: 1797394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. d-
    Mills SJ; Rossi AM; Konieczny V; Bakowski D; Taylor CW; Potter BVL
    J Med Chem; 2020 Mar; 63(6):3238-3251. PubMed ID: 32052631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ca2(+)-mobilising properties of synthetic fluoro-analogues of myo-inositol 1,4,5-trisphosphate and their interaction with myo-inositol 1,4,5-trisphosphate 3-kinase and 5-phosphatase.
    Safrany ST; Sawyer D; Wojcikiewicz RJ; Nahorski SR; Potter BV
    FEBS Lett; 1990 Dec; 276(1-2):91-4. PubMed ID: 2176165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The preparation of intermediates for the synthesis of 1D-myo-inositol 1,4,5- and 2,4,5-trisphosphates, 1,4-bisphosphate 5-phosphorothioate, and 4,5-bisphosphate 1-phosphorothioate from 1D-3,6-di-O-benzyl-1,2-O-isopropylidene-myo-inositol.
    Desai T; Gigg J; Gigg R; Martín-Zamora E
    Carbohydr Res; 1994 Sep; 262(1):59-77. PubMed ID: 7954520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of D- and L-myo-inositol 2,4,5-trisphosphate and trisphosphorothioate: structural analogues of D-myo-inositol 1,4,5-trisphosphate.
    Mills SJ; Liu C; Potter BV
    Carbohydr Res; 2002 Nov; 337(20):1795-801. PubMed ID: 12431881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of D- and L-myo-inositol 1,2,4,6-tetrakisphosphate, regioisomers of myo-inositol 1,3,4,5 tetrakisphosphate: activity against Ins(1,4,5)P3 binding proteins.
    Mills SJ; Backers K; Erneux C; Potter BV
    Org Biomol Chem; 2003 Oct; 1(20):3546-56. PubMed ID: 14599016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. myo-inositol 1,4,6-trisphosphorothioate and myo-inositol 1,3, 6-trisphosphorothioate: partial agonists with very low intrinsic activity at the platelet myo-inositol 1,4,5-trisphosphate receptor.
    Murphy CT; Riley AM; Mills SJ; Lindley CJ; Potter BV; Westwick J
    Mol Pharmacol; 2000 Mar; 57(3):595-601. PubMed ID: 10692501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, calcium mobilizing, and physicochemical properties of D-chiro-inositol 1,3,4,6-tetrakisphosphate, a novel and potent ligand at the D-myo-inositol 1,4,5-trisphosphate receptor.
    Liu C; Davis RJ; Nahorski SR; Ballereau S; Spiess B; Potter BV
    J Med Chem; 1999 Jun; 42(11):1991-8. PubMed ID: 10354407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modification at C2 of myo-inositol 1,4,5-trisphosphate produces inositol trisphosphates and tetrakisphosphates with potent biological activities.
    Wilcox RA; Safrany ST; Lampe D; Mills SJ; Nahorski SR; Potter BV
    Eur J Biochem; 1994 Jul; 223(1):115-24. PubMed ID: 8033885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. D-myo-inositol 1,4,5-trisphosphate analogues modified at the 3-position inhibit phosphatidylinositol 3-kinase.
    Ward SG; Mills SJ; Liu C; Westwick J; Potter BV
    J Biol Chem; 1995 May; 270(20):12075-84. PubMed ID: 7744856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.